About This Webinar
This webinar will provide an overview of the state of the art in hyperspectral imaging, discussing the major architectures for hyperspectral imagers together with their performance trade-offs. Specifically, presenter Hod Finkelstein, Ph.D, will describe a recent implementation of an autonomous, high-resolution, cost-efficient hyperspectral camera. A number of applications spanning medical imaging to agriculture and anti-counterfeiting will also be discussed. The webinar will conclude with an outlook on some of the exciting new technologies that are expected to continue to transform this imaging modality and move it into the domain of the consumer.
Finkelstein is CTO of TruTag Technologies where he leads imaging systems development and microparticle productization teams. He was previously director of technology development at Illumina and CTO at Vitasense Technologies, a CMOS single photon detector company. He holds a Ph.D. in biophotonics from the University of California, San Diego (UCSD), an MBA from Northwestern University’s Kellogg School of Management and Tel-Aviv University, and electrical engineering degrees from Technion, Israel and Cornell University.
This webinar is presented by
TruTag Technologies, a leading security and technology solutions provider serving businesses and governments around the world.
Read
Intelligent Hyperspectral Imaging Holds Promise for Pathology, an article by Hod Finkelstein, Ron R. Nissim and Mark J. Hsu, in the July/August 2017 issue of Biophotonics.